Babafig 🇷🇪

Orthopedic Devices Market Role in Musculoskeletal Disorder Treatment

7 دقيقة قراءة
0
التعليقات
43
المشاهدات

The global Orthopedic Devices Market is witnessing steady growth as the prevalence of musculoskeletal disorders, degenerative bone diseases, fractures, and sports-related injuries continues to increase. The market was valued at USD 60.4 billion in 2023 and is projected to grow from USD 68.1 billion in 2026 to USD 80.8 billion by 2030, registering a CAGR of 4.3% from 2024 to 2030. An aging global population, rising road accidents, advancements in orthopedic technologies, and growing adoption of minimally invasive surgical procedures are supporting market development. Increasing investments in healthcare infrastructure and the availability of advanced treatment solutions are further strengthening demand across hospitals and outpatient facilities.

Orthopedic Devices Market Overview and Key Industry Insights

Orthopedic devices are used to treat conditions affecting bones, joints, ligaments, tendons, and other components of the musculoskeletal system. These devices play an important role in joint replacement, fracture treatment, spinal procedures, sports injury management, and rehabilitation. Technological advancements and improvements in surgical techniques are expanding their applications across different healthcare settings.

North America accounted for the largest regional revenue share of 45% in 2023. The United States represented 93.3% of the North American market during the same year. By product, joint replacement and orthopedic implants dominated with a revenue share of 41.7%. Hospitals remained the leading end-use segment, accounting for 64.5% of global market revenue.

Asia Pacific is expected to register the fastest regional growth during the forecast period, supported by improving healthcare infrastructure, rising medical tourism, and increasing demand for orthopedic procedures.

Want to Understand What’s Driving Market Growth? Ask Prism AI for research-backed insights into market size, evolving opportunities

Factors Driving the Growth of the Orthopedic Devices Market

The increasing incidence of orthopedic disorders is a major factor supporting market expansion. Sedentary lifestyles and obesity are contributing to the early onset of musculoskeletal conditions. According to the Lancet Rheumatology report cited in the source, the global number of people with other musculoskeletal disorders increased by 123.4% between 1990 and 2020, rising from 221 million to 494 million. Cases are projected to increase by another 115% between 2020 and 2050, reaching approximately 1,060 million.

The growing aging population is also increasing the need for orthopedic treatment solutions. Bone density declines with age, increasing the risk of fractures, osteoporosis, and degenerative joint conditions. The global population aged 60 years and older is expected to reach 2.1 billion by 2050, creating greater demand for joint replacement procedures and other orthopedic interventions.

Technological Advancements Transforming Orthopedic Treatment

Innovation in orthopedic procedures is changing the way musculoskeletal conditions are treated. Robotic-assisted surgery is gaining attention because it supports precision, personalized treatment planning, and improved surgical execution. Advanced imaging and real-time feedback allow surgeons to tailor procedures to individual anatomical characteristics while reducing tissue disruption and potential complications.

Stryker UK Limited reports that approximately 13,000 patients worldwide undergo Mako robotic arm surgery every month. The increasing use of robotic technologies reflects the growing role of advanced surgical systems in joint replacement procedures.

Research and development activities are also supporting improvements in orthopedic implants. In November 2023, researchers from UCLA School of Dentistry developed a dental implant technique involving a one-minute ultraviolet light treatment of titanium implants. The process removes hydrocarbons from the implant surface and reduces the risk of post-treatment complications.

Minimally invasive surgical techniques are another important development. Greater awareness of these procedures and their potential benefits is supporting adoption across healthcare facilities.

Download a free sample report or claim your copy of this full market intelligence report

Product Segment Analysis: Implants Lead, Ortho-Biologics Gain Momentum

Joint replacement and orthopedic implants represented the largest product segment in 2023, accounting for 41.7% of market revenue. Demand is supported by the increasing number of hip and knee replacement procedures worldwide. According to the American College of Rheumatology, more than 450,000 hip replacements and over 790,000 knee replacements are performed annually in the United States.

Robotic-assisted joint replacement procedures are further contributing to segment development. A study examining computer-assisted total knee arthroplasty in Germany found that robot-assisted procedures increased significantly between 2018 and 2021, with an average annual increase rate of 84.74%.

The ortho-biologics segment is expected to register the fastest CAGR during the forecast period. Increasing product development and strategic initiatives by industry participants are supporting its expansion. In July 2023, Anika Therapeutics received FDA 510(k) clearance for further use of its Tactoset injectable bone substitute with autologous bone marrow aspirate. In June 2022, Istos Biologics introduced its Influx Fibrant product line, which includes five products made from 100% cortical allograft.

End-Use Trends: Hospitals Maintain Their Leading Position

Hospitals accounted for the largest end-use revenue share of 64.5% in 2023. Their established infrastructure, availability of specialized treatment solutions, and capacity to manage complex orthopedic procedures support their leading position. Hospital admissions associated with fractures, road accidents, and bone injuries also contribute to segment demand.

The hospital segment is projected to register a CAGR of 4.4% during the forecast period. Favorable reimbursement policies and the presence of hospitals and primary care centers across developed and developing economies are additional supporting factors.

Outpatient facilities are also gaining importance as patients increasingly consider day care centers and ambulatory surgery centers for selected procedures. These facilities offer shorter waiting periods, faster discharge, lower procedural costs, and improved treatment efficiency. Better postoperative pain management and reduced recovery-related disruption further support their adoption.

Regional Market Performance and Growth Opportunities

North America maintained its leading position in 2023 with a 45% revenue share. Established healthcare infrastructure, comprehensive reimbursement coverage, and the presence of major industry participants support regional demand. Increasing trauma cases, a growing elderly population, and the introduction of biodegradable and internal fixation devices are also contributing to market development.

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs.

The United States represented 93.3% of North American revenue in 2023. High rates of orthopedic disorders, joint surgeries, technological advancements, and strong distribution networks support the country's market position. Canada is expected to record the fastest CAGR in the region. In February 2024, Tyber Medical received Health Canada clearance for its anatomical plating system.

Asia Pacific is anticipated to be the fastest-growing regional market. Healthcare infrastructure improvements in India, China, and Japan, along with expanding medical tourism, are supporting demand. China is expected to register the fastest country-level CAGR within the region, although high procedure costs and strict device approval policies may restrict growth.

Europe is projected to experience significant growth, supported by rising healthcare expenditure and an aging population. Germany and the UK represent important markets due to demand associated with osteoarthritis, osteoporosis, bone injuries, and orthopedic implants.

Future Outlook

The orthopedic devices market is expected to maintain steady growth through 2030 as aging populations, musculoskeletal disorders, road accidents, and sports injuries continue to generate demand for treatment solutions. Joint replacement and orthopedic implants will remain important product categories, while ortho-biologics and robotic-assisted procedures offer additional development opportunities.

Continued investment in research, advanced manufacturing, minimally invasive techniques, and healthcare infrastructure will influence the industry's future direction. With the global market projected to reach USD 80.8 billion by 2030, innovation and expanding access to orthopedic treatment are expected to remain central to market development.

Explore Our Research & Intelligence Solutions

U.S. Healthcare Facility Intelligence: Make Better Decisions with Comprehensive Data – Explore the Platform

 

مموّل